<DOC>
	<DOCNO>NCT00002223</DOCNO>
	<brief_summary>The purpose study determine many HIV-infected patient continue take ritonavir/indinavir combination take indinavir three time day part anti-HIV drug therapy . This study also examine safety effectiveness ritonavir/indinavir combination .</brief_summary>
	<brief_title>A Study Ritonavir/Indinavir Combination HIV-Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Indinavir</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV infection . CD4 cell count great 100 cells/microliter . HIV RNA level great 400 copies/microliter use Roche Ultrasensitive assay . No acute illness . Consent parent guardian less legal age . No prior enrollment study . All entry criterion study meet within 15 day prior enrollment . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Any condition opinion investigator may obscure proper observation safety activity treatment regimen use study . Concurrent Medication : Excluded : Concurrent nonnucleoside reverse transcriptase inhibitor part antiretroviral regimen . Any following medication ritonavir : midazolam , clorazepate , diazepam , estazolam , flurazepam , triazolam , zolpidem , quinidine , amiodarone , encainide , flecainide , propafenone , bepridil , terfenadine , astemizole , cisapride , bupropion , clozapine , rifabutin , meperidine , propoxyphene , piroxicam , pimozide , dihydroergotamine , ergotamine . Any following medication indinavir : terfenadine , astemizole , cisapride , triazolam , midazolam . No requirement rifampin ketoconazole . Any concurrent treatment protease inhibitor . Other concurrent medication ( include overthecounter medicine alcohol ) without knowledge permission primary investigator . Patients follow prior condition exclude : History significant drug hypersensitivity . Psychiatric illness precludes compliance protocol . Receipt investigational drug within 30 day prior administration study drug . History acute chronic pancreatitis . Anticipation poor patient compliance protocol . Prior Medication : Excluded : Prior treatment ritonavir . Risk Behavior : Excluded : History active substance abuse ( i.e. , recreational drug alcohol ) . Included : Indinavir 800 mg three time day plus unspecified nucleoside least 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Adolescent Behavior</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Ritonavir</keyword>
	<keyword>Indinavir</keyword>
</DOC>